Brand Information

Updated On: 20-08-2024

Home

About Us

FAQs

Feedback

Disclaimer

Site Map

Home > Search > > > FLOHALE INHALER

FLOHALE INHALER

Brand:
FLOHALE INHALER

Manufacturer:
CIPLA

Manufacturer Details
CIPLA

Compositions:
Fluticasone propionate 25mcg/50mcg/125mcg per metered dose Inhaler,

Strength	Rate	Packing Style
125mcg	272.00	120 doses
25mcg	130.00	120 doses
50mcg	219.00	120 doses

List of Related Indications:

Asthma

List Of Drugs:

Fluticasone propionate @ - Topical corticosteroids- (FDC- List ) -(Mar 1996)

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Interaction with Food

Pregnancy and lactation

Drug Interaction:

Corticosteroids topical include-

Alcometasone dipropionate, Amcinonide, Betamethasone benzoate, dipropionate, valerate, Clobetasol propionate, clocortolone pivalate, Desonide, Desoximetasone, Dexamethasone, Diflorasone, Fluocinolone acetonide,Fluocinonide, Flurandrenolide, Fluticasone propionate, Halcinode, Halobetasol Propionate, Hydrocortisone, Methylprednisolone acetate, Mometasone furoate, Prednicarbate, Triamcinolone acetonide

Refer - Betamethasone

Indication:

Prophylaxis of allergic rhinitis

Approved by (DCI) Drug Controller GENERAL - India For Marketing

(Ref- IDMA Publication)

Name of Drug Indication Date of Approval

1.Fluticasone Propionate 18-03-1996

Inflammatory & Pruritic manifestation of corticosteroid

responsive eczema dermatitis

2.Fluticasone Furoate Nasal Spray 14-11-2009

27.5mcg per spray

For the reduction of symptoms of allergic rhinitis

3. Fluticasone propionate 25-05-2010

50mcg/123mcg/250mcg

+ Salbutamol xinafoate 25mcg/25mcg/25mcg

Powder for inhalation

For the maintenance treatment of asthma and for treatment of

COPD associated with chronic bronchitis

FIXED DOSE COMBINATIONS APPROVED BY DCG(I)

FROM JANUARY 1961 TILL NOVEMBER 2014

Name of Drug Indication Date of Approval

1.Fluticasone Propionate 500mcg/250mcg/100mcg+ 29-03-2000

Salmeterol Xinofoate 50mcg Accuhaler

For regular treatment of Bronchial Asthma where

use a Bronchodilator and an inhaled corticostroids

are appropiate

2.Flucticasone Propionate 500mcg/250mcg/100mcg + 29-03-2000

Salmeterol Xinafoate 50mcg/50mcg/50mcg inhaltion

powder

For regular treatment of bronchial Asthma where

use of a bronchodilator and an inhaled corticosteroid

are appropiate

3. Flucticssone Propionate 50mcg/125mcg/250mg + 25-05-2010

Salmeterol Xinafoate 25mcg/25mcg/25mcg Powder

for Inhalation

For the maintenance treatment of asthma and for the

treatment of COPD associated with chronic bronchitis

Patent Expiry Date of drugs (Ref - IDMA Publication)

Chemical Category Manufacturer/ US Patent

Ingredient- Marketer Expiration Date

Fluticasone Respiratory Glaxo Wellcome 14-11-2003

Fluticasone Respiratory GlaxoSmithKline 14-11-2003

Corticosteroids topical include-

Alcometasone dipropionate, Amcinonide, Betamethasone benzoate, dipropionate, valerate,

Clobetasol propionate, clocortolone pivalate, Desonide, Desoximetasone, Dexamethasone,

Diflorasone, Fluocinolone acetonide,Fluocinonide, Flurandrenolide, Fluticasone propionate,

Halcinode, Halobetasol Propionate, Hydrocortisone, Methylprednisolone acetate,

Mometasone furoate, Prednicarbate, Triamcinolone acetonide

Refer - Betamethasone

Adverse Reaction:

Inhaltion therapy is well tolerated with almost nil systemic effects at recommended dosage. Adverse reactions reported are- oropharyngeal candidiasis, pharyngitis, dysphonia, cough, nasal congestion, rhinitis and headache

Contra-Indications:

Hypersensitivity Children under 4 years Primary treatment of acute asthmatic episodes and status asthmaticus.

Dosages/ Overdosage Etc:

Date of Approval 1996

Indication

Prophylaxis of allergic rhinitis

Dosage-

100-mcg by inhalation into each nostril once daily. increased to 100mcg bid

Children- (4-16 years) 50- 100mcg once daily increased to 50mcg b.i.d.

Patient Information:

Corticosteroids topical include-

Refer - Betamethasone

Patients are advised to rinse their mouths with water every time after inhalation to minimise the risk of candidial infection.

Pharmacology/ Pharmacokinetics:

Rrefer Topical corticosteroids

Interaction with Food:

Not available

Pregnancy and lactation:

Refer Topical Corticosteroidsteroids

Search

Look In

Keyword

Mode

	Starts With		Contains

Quick Links

Home
About Us
FAQs
Site Map
Disclaimer

Free Mobile App

About Us

FAQs

Feedback

Disclaimer: Every effort has been made to ensure that the information provided in this Database is authentic and accurate. Commissions or omissions in the database, if any, are purely inadvertent and the site owner shall not accept any liability whatsoever for any adverse consequences of any nature arising to any individual or third party, as a result of usage of this information.